Stochastic model of Alzheimer's disease progression using two-state Markov chains

PLoS One. 2024 Jan 19;19(1):e0295578. doi: 10.1371/journal.pone.0295578. eCollection 2024.

Abstract

In 2016, Hao and Friedman developed a deterministic model of Alzheimer's disease progression using a system of partial differential equations. This model describes the general behavior of the disease, however, it does not incorporate the molecular and cellular stochasticity intrinsic to the underlying disease processes. Here we extend the Hao and Friedman model by modeling each event in disease progression as a stochastic Markov process. This model identifies stochasticity in disease progression, as well as changes to the mean dynamics of key agents. We find that the pace of neuron death increases whereas the production of the two key measures of progression, Tau and Amyloid beta proteins, decelerates when stochasticity is incorporated into the model. These results suggest that the non-constant reactions and time-steps have a significant effect on the overall progression of the disease.

MeSH terms

  • Alzheimer Disease*
  • Amyloid beta-Peptides
  • Disease Progression
  • Humans
  • Markov Chains
  • Stochastic Processes
  • tau Proteins

Substances

  • Amyloid beta-Peptides
  • tau Proteins